Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

CSL Limited (ASX:CSL)

Pharmaceuticals, Biotechnology & Life Sciences

CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.

CSL Limited (ASX:CSL) share price

CSL Limited (ASX:CSL) share price news

ASX-healthcare
ASX Share Ideas
David Lennan

Is The CSL Share Price A Buy After Its AGM?

The CSL Limited (ASX:CSL) share price hit a new all-time high today following the company’s annual general meeting (AGM). Is it time to buy CSL shares?

uncle-sam-new-usa-america
ASX Share Ideas
Max Wagner

3 ASX Growth Shares With USD Exposure

If the Australian dollar continues to fall against the US dollar, I think it’s worth looking at shares of CSL Limited (ASX: CSL), Cochlear Limited (ASX: COH) and Altium Limited (ASX: ALU).

Businessman with red boxing gloves ready to fight his coworker.
Today's ASX news
Max Wagner

Is The SPDR ASX 50 ETF (SFY) Better Than A200?

There are several ASX ETFs designed to track the S&P/ASX 200 (INDEXASX: XJO) but only one to track the top 50 companies on the ASX. How does the SPDR S&P/ASX 50 Fund (ASX: SFY) compare?

ASX ETF
Today's ASX news
Max Wagner

Is The iShares Edge AUMF ETF Really Worth It?

The iShares Edge MSCI Australia Multifactor ETF (ASX: AUMF) is coming up on three years listed on the ASX. Here’s a review of how it has performed and what the outlook could be.

Skip to content